RÉSUMÉ
BACKGROUND: Tumor-associated macrophages (TAM) are known to facilitate colorectal cancer (CRC) growth. High macrophage infiltration in thymidine phosphorylase (TYMP) expressing CRC may correspond to poor prognosis. The prognostic impact of the expression CD163, a receptor associated with TAM, and TYMP in stroma, respectively, tumor tissue is not yet established. The aim of this study was to identify the potential associations between TYMP and CD163 expression levels and relapse-free survival (RFS) of patients with stage II CRC, and if microdissection is of importance. METHODS: Stage II CRC patients, radically resected with relapse (n = 104), were matched to patients with a 5-year relapse-free follow-up (n = 206). Gene expression of TYMP and CD163 was analyzed in snap-frozen tumor tissues and in microdissected formalin-fixed tumor tissues separated into tumor epithelium and stroma. RESULTS: TYMP expression was high in poorly differentiated tumors, right-sided CRC, and tumors with high microsatellite instability CD163-expressing macrophages near tumor epithelial cells had high expression in poorly differentiated and T4 tumors. High TYMP expression in tumor epithelial cells was in the multivariate analyses associated with shorter relapse-free survival (hazard ratio 1.66; 95% confidence interval: 1.09-2.56; p < 0.05). CONCLUSIONS: TYMP expression in tumor epithelial cells was associated with RFS and emphasizes the need for tissue microdissection. Additional studies are needed to establish whether TYMP and CD163 could add clinically relevant information to identify high-risk stage II patients that could benefit from adjuvant chemotherapy.
Sujet(s)
Antigènes CD , Antigènes de différenciation des myélomonocytes , Tumeurs colorectales , Thymidine phosphorylase , Antigènes CD/génétique , Antigènes de différenciation des myélomonocytes/génétique , Marqueurs biologiques tumoraux/génétique , Marqueurs biologiques tumoraux/métabolisme , Tumeurs colorectales/anatomopathologie , Humains , Récidive tumorale locale/anatomopathologie , Pronostic , Récepteurs de surface cellulaire , Thymidine phosphorylase/génétiqueRÉSUMÉ
Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling. Recent evidence supports that inflammation plays a key role in triggering and maintaining pulmonary vascular remodeling. Recent studies have shown that garlic extract has protective effects in PAH, but the precise role of allicin, a compound derived from garlic, is unknown. Thus, we used allicin to evaluate its effects on inflammation and fibrosis in PAH. Male Wistar rats were divided into three groups: control (CON), monocrotaline (60 mg/kg) (MCT), and MCT plus allicin (16 mg/kg/oral gavage) (MCT + A). Right ventricle (RV) hypertrophy and pulmonary arterial medial wall thickness were determined. IL-1ß, IL-6, TNF-α, NFκB p65, Iκß, TGF-ß, and α-SMA were determined by Western blot analysis. In addition, TNF-α and TGF-ß were determined by immunohistochemistry, and miR-21-5p and mRNA expressions of Cd68, Bmpr2, and Smad5 were determined by RT-qPCR. Results: Allicin prevented increases in vessel wall thickness due to TNF-α, IL-6, IL-1ß, and Cd68 in the lung. In addition, TGF-ß, α-SMA, and fibrosis were lower in the MCT + A group compared with the MCT group. In the RV, allicin prevented increases in TNF-α, IL-6, and TGF-ß. These observations suggest that, through the modulation of proinflammatory and profibrotic markers in the lung and heart, allicin delays the progression of PAH.
Sujet(s)
Anti-inflammatoires/usage thérapeutique , Disulfures/usage thérapeutique , Hypertension pulmonaire/traitement médicamenteux , Acides sulfiniques/usage thérapeutique , Animaux , Antigènes CD/génétique , Antigènes CD/métabolisme , Antigènes de différenciation des myélomonocytes/génétique , Antigènes de différenciation des myélomonocytes/métabolisme , Récepteurs de la protéine morphogénique osseuse de type II/génétique , Récepteurs de la protéine morphogénique osseuse de type II/métabolisme , Cytokines/génétique , Cytokines/métabolisme , Fibrose , Ventricules cardiaques/effets des médicaments et des substances chimiques , Ventricules cardiaques/métabolisme , Ventricules cardiaques/anatomopathologie , Mâle , Facteur de transcription NF-kappa B/génétique , Facteur de transcription NF-kappa B/métabolisme , Artère pulmonaire/effets des médicaments et des substances chimiques , Artère pulmonaire/métabolisme , Artère pulmonaire/anatomopathologie , Rats , Rat Wistar , Protéine Smad-5/génétique , Protéine Smad-5/métabolismeRÉSUMÉ
PURPOSE: To study the effector mechanism against pathogens of polymorphonuclear neutrophils (PMN) and macrophages, called ETosis, involving the release of extracellular traps (ETs) in patients with acute epididymitis. To assess the different ET phenotypes present in semen samples and to identify correlations between ETosis and clinical parameters. MATERIALS AND METHODS: Samples from patients diagnosed with acute epididymitis were examined and compared with samples from uninfected controls. Biochemical analyses of seminal fluid included determination of peroxidase, α-glucosidase, fructose, and elastase levels. ETosis in semen was determined through presence of citrullinated histones, global histones, and extracellular DNA. Different ETosis phenotypes such as spread ETs, aggregated ETs, and diffuse ETs were identified by co-localisation of extruded DNA with myeloperoxidase and global histones. Anti-CD15+ and anti-CD68+ antibodies were used to identify different cell lines. RESULTS: Revealed a high number of ETs compared with the control group. The mean number of CD15+PMN and CD68+ macrophages was higher in the acute epididymitis group. ETosis increase in ejaculates correlated with clinical parameters such as enhancement of elastase concentrations and diminution of fructose in the semen. CONCLUSIONS: This work shows for the first time the presence of ETs and their components in semen from patients with acute epididymitis. The presence of infections is an important factor for induction of ETs in semen. Furthermore, the presence of ETosis in ejaculates is suggestive of developing infectious processes and might possibly have a diagnostic value.
Sujet(s)
Épididymite/génétique , Pièges extracellulaires/génétique , Leucocytes/métabolisme , Sperme/métabolisme , Adulte , Antigènes CD/génétique , Antigènes de différenciation des myélomonocytes/génétique , Lignée cellulaire , Citrullination/génétique , Épididymite/diagnostic , Épididymite/métabolisme , Épididymite/anatomopathologie , Pièges extracellulaires/métabolisme , Femelle , Fructose/métabolisme , Histone/génétique , Humains , Leucocytes/anatomopathologie , Antigènes CD15/génétique , Mâle , Adulte d'âge moyen , Pancreatic elastase/métabolisme , Myeloperoxidase/métabolisme , Projets pilotes , alpha-Glucosidase/métabolismeRÉSUMÉ
Niemannâ»Pick type C (NPC) disease is a rare neurovisceral cholesterol storage disorder that arises from loss of function mutations in the NPC1 or NPC2 genes. Soon after birth, some patients present with an aggressive hepatosplenomegaly and cholestatic signs. Histopathologically, the liver presents with large numbers of foam cells; however, their role in disease pathogenesis has not been explored in depth. Here, we studied the consequences of gadolinium chloride (GdCl3) treatment, a well-known Kupffer/foam cell inhibitor, at late stages of NPC liver disease and compared it with NPC1 genetic rescue in hepatocytes in vivo. GdCl3 treatment successfully blocked the endocytic capacity of hepatic Kupffer/foam measured by India ink endocytosis, decreased the levels CD68-A marker of Kupffer cells in the liver-and normalized the transaminase levels in serum of NPC mice to a similar extent to those obtained by genetic Npc1 rescue of liver cells. Gadolinium salts are widely used as magnetic resonance imaging (MRI) contrasts. This study opens the possibility of targeting foam cells with gadolinium or by other means for improving NPC liver disease. Synopsis: Gadolinium chloride can effectively rescue some parameters of liver dysfunction in NPC mice and its potential use in patients should be carefully evaluated.
Sujet(s)
Gadolinium/pharmacologie , Cellules de Küpffer/effets des médicaments et des substances chimiques , Maladie de Niemann-Pick de type C/traitement médicamenteux , Animaux , Antigènes CD/génétique , Antigènes CD/métabolisme , Antigènes de différenciation des myélomonocytes/génétique , Antigènes de différenciation des myélomonocytes/métabolisme , Endocytose , Gadolinium/usage thérapeutique , Protéines et peptides de signalisation intracellulaire , Cellules de Küpffer/métabolisme , Souris , Souris de lignée BALB C , Protéine NPC1 , Protéines/génétique , Protéines/métabolismeRÉSUMÉ
Macrophages play a very important role in the conduction of several regenerative processes mainly due to their plasticity and multiple functions. In the muscle repair process, while M1 macrophages regulate the inflammatory and proliferative phases, M2 (anti-inflammatory) macrophages direct the differentiation and remodelling phases, leading to tissue regeneration. The aim of this study was to evaluate the effect of red and near infrared (NIR) photobiomodulation (PBM) on macrophage phenotypes and correlate these findings with the repair process following acute muscle injury. Wistar rats were divided into 4 groups: control; muscle injury; muscle injury + red PBM; and muscle injury + NIR PBM. After 2, 4 and 7 days, the tibialis anterior muscle was processed for analysis. Macrophages phenotypic profile was evaluated by immunohistochemistry and correlated with the different stages of the skeletal muscle repair by the qualitative and quantitative morphological analysis as well as by the evaluation of IL-6, TNF-α and TGF-ß mRNA expression. Photobiomodulation at both wavelengths was able to decrease the number of CD68+ (M1) macrophages 2 days after muscle injury and increase the number of CD163+ (M2) macrophages 7 days after injury. However, only NIR treatment was able to increase the number of CD206+ M2 macrophages (Day 2) and TGF-ß mRNA expression (Day 2, 4 and 7), favouring the repair process more expressivelly. Treatment with PBM was able to modulate the inflammation phase, optimize the transition from the inflammatory to the regeneration phase (mainly with NIR light) and improve the final step of regeneration, enhancing tissue repair.
Sujet(s)
Photothérapie de faible intensité , Développement musculaire/effets des radiations , Muscles/effets des radiations , Régénération/effets des radiations , Animaux , Antigènes CD/génétique , Antigènes de différenciation des myélomonocytes/génétique , Différenciation cellulaire/effets des radiations , Humains , Macrophages/anatomopathologie , Macrophages/effets des radiations , Muscles squelettiques/croissance et développement , Muscles squelettiques/traumatismes , Muscles squelettiques/effets des radiations , Muscles/traumatismes , Muscles/anatomopathologie , Rats , Récepteurs de surface cellulaire/génétique , Cicatrisation de plaie/physiologie , Cicatrisation de plaie/effets des radiationsRÉSUMÉ
Leprosy is a chronic granulomatous infection that manifests as different clinical forms related to the immunological response. The aim of the study was to evaluated the response of IL-22, STAT3, CD68 and iNOS in leprosy skin lesions. The mean number IL-22 positive cells was 12.12±1.90cells/field in the TT form and 31.31±2.91cells/field in the LL form. STAT3 positive cells was 5.29±1.96 cells/field in the TT form, while this number was 11.13±3.48cells/field in the LL form. The mean number of CD68 positive cells was 25.18±6.21cells/field in the TT form and 62.81±8.13cells/field in the LL form. Quantitative analysis of iNOS revealed a significant difference, with the mean number of cells expressing the enzyme being 30.24±2.88cells/field in the TT form compared to 35.44±4.69cells/field in the LL form. Linear correlations in lesions of TT patients showed a moderate positive correlations between CD68 and iNOS, STAT3 and Inos, IL-22 and STAT3, and IL-22 and iNOS. Our results demonstrate that these factors can act synergistically to induce a microbicidal activity in the population of macrophages in the leprosy lesions.
Sujet(s)
Antigènes CD/métabolisme , Antigènes de différenciation des myélomonocytes/métabolisme , Interleukines/métabolisme , Lèpre/métabolisme , Macrophages/métabolisme , Nitric oxide synthase type II/métabolisme , Facteur de transcription STAT-3/métabolisme , Antigènes CD/génétique , Antigènes de différenciation des myélomonocytes/génétique , Femelle , Régulation de l'expression des gènes/immunologie , Humains , Interleukines/génétique , Macrophages/immunologie , Mâle , Nitric oxide synthase type II/génétique , Facteur de transcription STAT-3/génétique , Interleukin-22RÉSUMÉ
BACKGROUND: Lipopolysaccharide (LPS)-tolerant monocytes produce small amounts of inflammatory cytokines, which is one of the characteristics of the alternative activated macrophages (AAM). These cells exhibited an increased expression of CD206 and CD163. Given the functional similarities of AAMs with the modulation of monocytes' functions observed during sepsis and LPS-tolerance, we evaluated whether the inhibition of inflammatory cytokine production by LPS-tolerant monocytes is associated with the phenotype of cells expressing CD206 and CD163. METHODS: We investigated whether tolerant human monocytes would modulate their expression of CD206 and CD163, markers of alternative activation, and whether the level of their expression would be related to cytokines detection. Tolerance to LPS was induced in peripheral blood mononuclear cell by pre-incubating the cells with increasing concentrations of LPS. The expression of CD206 and CD163 and intracellular TNF-α and IL-6 was determined 24 h after LPS challenge by flow cytometry. RESULTS: No differences in CD163 expression were observed between tolerant and non-tolerant cells, while the expression of CD206, which was decreased following LPS stimulation in non-tolerized cells, was further reduced in tolerant cells. Decreased production of inflammatory cytokines was observed in the tolerized cells, regardless of the expression of CD163 and CD206, with the exception of IL-6 in CD206+ monocytes, which was similarly expressed in both tolerized and non-tolerized cells. CONCLUSIONS: The effect of LPS in the expression of CD163 and CD206 on monocytes is not reverted in LPS tolerant cells, and the inhibition of inflammatory cytokines in tolerant cells is not related with modulation of these receptors. © 2016 International Clinical Cytometry Society.
Sujet(s)
Antigènes CD/génétique , Antigènes de différenciation des myélomonocytes/génétique , Tolérance immunitaire/génétique , Lectines de type C/génétique , Macrophages/immunologie , Lectines liant le mannose/génétique , Récepteurs de surface cellulaire/génétique , Adulte , Antigènes CD/immunologie , Antigènes de différenciation des myélomonocytes/immunologie , Cytokines/biosynthèse , Cytokines/immunologie , Femelle , Cytométrie en flux , Régulation de l'expression des gènes/immunologie , Humains , Lectines de type C/immunologie , Agranulocytes/effets des médicaments et des substances chimiques , Agranulocytes/immunologie , Lipopolysaccharides/toxicité , Activation des lymphocytes/effets des médicaments et des substances chimiques , Activation des lymphocytes/génétique , Activation des lymphocytes/immunologie , Macrophages/métabolisme , Mâle , Récepteur du mannose , Lectines liant le mannose/immunologie , Monocytes/effets des médicaments et des substances chimiques , Monocytes/immunologie , Récepteurs de surface cellulaire/immunologie , Facteur de nécrose tumorale alpha/génétiqueRÉSUMÉ
Renal pathological changes in cirrhotic rat have not been extensively reported. The aim of this study was to investigate whether Xiayuxue decoction (XYXD) could attenuate renal injury induced by bile duct ligation (BDL), with special focus on the mechanisms promoting renal macrophage apoptosis. The rats were treated with BDL for 5 weeks and administered 0.36 g/kg XYXD intragastrically from day 1 of initiating BDL. Renal tissue was monitored by hematoxylin-eosin and Sirius red staining. Macrophage infiltration and proinflammatory cytokines such as tumor necrosis factor and chemokine ligand 2 were detected by quantitative polymerase chain reaction. Macrophage apoptosis was detected by double immunofluorescence staining. Blood urea nitrogen, creatinine, and glomerulus diameter increased significantly after a 5-week BDL treatment in XYXD (BDL-XYXD) rats. CD68 and pro-inflammatory cytokine mRNA increased in the kidneys of control (BDL-water) rats. Fluorescence microscopy analysis showed that XYXD promoted apoptosis in renal CD68+ macrophages. Collogen1 (Col 1), pro-fibrogenic cytokines, and α-smooth muscle actin in kidneys of BDL-water rats increased significantly compared to the sham group. XYXD inhibited Col 1 and pro-fibrotic factors in BDL-XYXD rats. Our results demonstrated that XYXD significantly reduced renal injury by, at least in part, promoting macrophage apoptosis in rats with damaged renal histopathology due to BDL-induced cirrhosis.
Sujet(s)
Atteinte rénale aigüe/traitement médicamenteux , Apoptose/effets des médicaments et des substances chimiques , Médicaments issus de plantes chinoises/pharmacologie , Cirrhose du foie/traitement médicamenteux , Macrophages/effets des médicaments et des substances chimiques , Phytothérapie/méthodes , Actines/génétique , Actines/métabolisme , Atteinte rénale aigüe/étiologie , Atteinte rénale aigüe/génétique , Atteinte rénale aigüe/anatomopathologie , Animaux , Antigènes CD/génétique , Antigènes CD/métabolisme , Antigènes de différenciation des myélomonocytes/génétique , Antigènes de différenciation des myélomonocytes/métabolisme , Conduits biliaires/anatomopathologie , Conduits biliaires/chirurgie , Azote uréique sanguin , Mouvement cellulaire , Chimiokine CCL2/génétique , Chimiokine CCL2/métabolisme , Cholestase/complications , Cholestase/génétique , Cholestase/anatomopathologie , Collagène de type I/génétique , Collagène de type I/métabolisme , Créatinine/sang , Expression des gènes , Rein/effets des médicaments et des substances chimiques , Rein/métabolisme , Rein/anatomopathologie , Ligature , Foie/effets des médicaments et des substances chimiques , Foie/métabolisme , Foie/anatomopathologie , Cirrhose du foie/étiologie , Cirrhose du foie/génétique , Cirrhose du foie/anatomopathologie , Macrophages/métabolisme , Macrophages/anatomopathologie , Mâle , Rats , Rat Wistar , Facteur de nécrose tumorale alpha/génétique , Facteur de nécrose tumorale alpha/métabolismeRÉSUMÉ
Professional antigen-presenting cells, dendritic cells (DCs) play an important role in controlling tumors. It is known that solid tumor cell products inhibit DC differentiation. Recently a similar effect produced by leukemic cell products has been demonstrated. In this case, leukemic cell products induced the secretion of IL-1ß by monocytes undergoing differentiation. The aim of the present work was to characterize and to compare the development of monocyte-derived DCs under the influence of leukemic cell products (K562 supernatant) or exogenous IL-1ß. It became clear that leukemic cell products and IL-1ß differentially modulate some of the parameters studied on monocytes stimulated to differentiate into DCs. In the presence of K562 supernatant, the expression of the macrophage markers CD16 and CD68 were higher than in immature DCs control. Contrasting with IL-1ß, leukemic cell products possibly favor the development of cells with macrophage markers. In addition, CD80 and CD83 expressions were also higher in the presence of tumor supernatant whereas HLA-DR was lower. In the presence of IL-1ß, only CD80 was increased. Furthermore, it was observed that when monocytes were induced to differentiate into DCs in the presence of tumor supernatant and then activated, they expressed less CD80 and CD83 than activated DCs control. A reduced expression of CD83 following activation was also seen in cells differentiated with IL-1ß. TGF-ß and VEGF were found in the tumor supernatants. Moreover, the exposure to tumor supernatant or IL-1ß stimulated IL-10 production while decreased IL-12 production by activated DCs. Finally, these results suggest that the addition of products released by leukemic cells or, more discreetly, the addition of IL-1ß affects DC differentiation, inducing a suppressive phenotype.
Sujet(s)
Milieux de culture conditionnés/pharmacologie , Cellules dendritiques/effets des médicaments et des substances chimiques , Interleukine-1 bêta/pharmacologie , Monocytes/effets des médicaments et des substances chimiques , Antigènes CD/génétique , Antigènes CD/immunologie , Antigènes de différenciation des myélomonocytes/génétique , Antigènes de différenciation des myélomonocytes/immunologie , Antigène CD80/génétique , Antigène CD80/immunologie , Communication cellulaire , Différenciation cellulaire , Techniques de coculture , Cellules dendritiques/cytologie , Cellules dendritiques/immunologie , Protéines liées au GPI/génétique , Protéines liées au GPI/immunologie , Expression des gènes , Génotype , Facteur de stimulation des colonies de granulocytes et de macrophages/pharmacologie , Antigènes HLA-DR/génétique , Antigènes HLA-DR/immunologie , Humains , Immunoglobulines/génétique , Immunoglobulines/immunologie , Interleukine-10/biosynthèse , Interleukine-10/métabolisme , Interleukine-12/biosynthèse , Interleukine-12/métabolisme , Interleukine-4/pharmacologie , Cellules K562 , Glycoprotéines membranaires/génétique , Glycoprotéines membranaires/immunologie , Monocytes/cytologie , Monocytes/immunologie , Phénotype , Culture de cellules primaires , Récepteurs du fragment Fc des IgG/génétique , Récepteurs du fragment Fc des IgG/immunologie , Facteur de nécrose tumorale alpha/pharmacologie , CD83 AntigenRÉSUMÉ
OBJECTIVE: Systemic sclerosis (SSc)-related interstitial lung disease (ILD) is one of the leading causes of mortality. We undertook this study to analyze the gene expression of lung tissue in a prospective cohort of patients with SSc-related ILD and to compare it with that in control lungs and with 2 prospective clinical parameters in order to understand the molecular pathways implicated in progressive lung disease. METHODS: Lung tissue was obtained by open lung biopsy in 28 consecutive patients with SSc-related ILD and in 4 controls. High-resolution computed tomography (HRCT) and pulmonary function testing (PFT) were performed at baseline and 2-3 years after treatment based on lung histologic classification. Microarray analysis was performed, and the results were correlated with changes in the HRCT score (FibMax) and PFT values. Quantitative polymerase chain reaction (qPCR) and immunohistochemistry were used to confirm differential levels of messenger RNA and protein. RESULTS: Lung microarray data distinguished patients with SSc-related ILD from healthy controls. In the lungs of patients with SSc-related ILD who had nonspecific interstitial pneumonia (NSIP), expressed genes included macrophage markers, chemokines, collagen, and transforming growth factor ß (TGFß)- and interferon (IFN)-regulated genes. Expression of these genes correlated with progressive lung fibrosis defined by the change in FibMax. Immunohistochemistry confirmed increased markers of collagen (COL1A1), IFN (OAS1 and IFI44), and macrophages (CCL18 and CD163), and the positive correlation with the change in FibMax was confirmed by qPCR in a larger group of SSc patients with NSIP. Several genes correlated with both the change in FibMax (r > 0.4) and the change in % predicted forced vital capacity (r < -0.1), including IFN and macrophage markers, chemokines, and heat-shock proteins. CONCLUSION: These results highlight major pathogenic pathways relevant to progressive pulmonary fibrosis in SSc-related ILD: macrophage emigration and activation, and up-regulated expression of TGFß- and IFN-regulated genes.
Sujet(s)
Poumon/métabolisme , Activation des macrophages/génétique , Fibrose pulmonaire/génétique , Sclérodermie systémique/génétique , 2',5'-Oligoadenylate synthetase/génétique , 2',5'-Oligoadenylate synthetase/métabolisme , Adulte , Antigènes/génétique , Antigènes/métabolisme , Antigènes CD/génétique , Antigènes CD/métabolisme , Antigènes de différenciation des myélomonocytes/génétique , Antigènes de différenciation des myélomonocytes/métabolisme , Chimiokines CC/génétique , Chimiokines CC/métabolisme , Collagène de type I/génétique , Collagène de type I/métabolisme , Chaine alpha-1 du collagène de type I , Protéines du cytosquelette/génétique , Protéines du cytosquelette/métabolisme , Évolution de la maladie , Femelle , Humains , Poumon/anatomopathologie , Poumon/physiopathologie , Mâle , Adulte d'âge moyen , Fibrose pulmonaire/étiologie , Fibrose pulmonaire/anatomopathologie , Fibrose pulmonaire/physiopathologie , Récepteurs de surface cellulaire/génétique , Récepteurs de surface cellulaire/métabolisme , Tests de la fonction respiratoire , Sclérodermie systémique/complications , Sclérodermie systémique/anatomopathologie , Sclérodermie systémique/physiopathologie , Facteur de croissance transformant bêta/génétique , Facteur de croissance transformant bêta/métabolismeRÉSUMÉ
The pentacyclic triterpene α,ß-amyrin has been previously reported as an effective compound in the treatment of several inflammatory conditions. Recent evidence indicates that α,ß-amyrin displayed its effects through interaction with the cannabinoid pathway. We assessed the anti-inflammatory effects of the α,ß-amyrin in the dextran sulfate sodium (DSS)-induced colitis in mice and investigated whether its effects were associated with the interaction with the cannabinoid system. Our results showed that the oral preventive or therapeutic treatment with α,ß-amyrin significantly reduced disease activity, body weight loss, colonic damage, as well as colonic myeloperoxidase and N-acetylglucosaminidase activities. Moreover, α,ß-amyrin decreases the colonic pro-inflammatory mediators tumor necrosis factor (TNF)-α, interleukin (IL)-1ß and keratinocyte-derived chemokine (CXCL1/KC), while up-regulating the IL-4 levels. Additionally, we also observed that the α,ß-amyrin caused a significant reduction of the adhesion molecules mRNA expression for intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), platelet cell adhesion molecule 1 (PCAM-1), ß(2)-integrin and protein expression for proliferation marker Ki67, the macrophage molecule CD68 and for adhesion molecule P-selectin. Interestingly, our results also showed that the cannabinoid receptor 1 (CB(1)), but not CB(2), pharmacological blockade significantly reversed the beneficial effects of α,ß-amyrin in DSS-induced colitis. Besides, our data demonstrated that mRNA expression for both the endocannabinoid hydrolase monoglyceride lipase 1 (MGL1) and fatty acid amide hydrolase (FAAH) were significantly reduced in the colon of α,ß-amyrin-treated mice. Altogether, these results suggest that the α,ß-amyrin might possess potential therapeutic interest for the treatment of IBD, and also provide new insights for the underlying mechanisms.
Sujet(s)
Cannabinoïdes/métabolisme , Colite/traitement médicamenteux , Colite/métabolisme , Acide oléanolique/analogues et dérivés , Administration par voie orale , Amidohydrolases/génétique , Amidohydrolases/métabolisme , Animaux , Antigènes CD/génétique , Antigènes CD/métabolisme , Antigènes de différenciation des myélomonocytes/génétique , Antigènes de différenciation des myélomonocytes/métabolisme , Asialoglycoprotéines/génétique , Asialoglycoprotéines/métabolisme , Poids/effets des médicaments et des substances chimiques , Poids/génétique , Antigènes CD18/génétique , Antigènes CD18/métabolisme , Cannabinoïdes/génétique , Molécules d'adhérence cellulaire/génétique , Molécules d'adhérence cellulaire/métabolisme , Chimiokines/génétique , Chimiokines/métabolisme , Colite/induit chimiquement , Colite/génétique , Côlon/effets des médicaments et des substances chimiques , Côlon/métabolisme , Sulfate dextran , Molécule-1 d'adhérence intercellulaire/génétique , Molécule-1 d'adhérence intercellulaire/métabolisme , Interleukine-1 bêta/génétique , Interleukine-1 bêta/métabolisme , Interleukine-4/génétique , Interleukine-4/métabolisme , Antigène KI-67/génétique , Antigène KI-67/métabolisme , Lectines de type C/génétique , Lectines de type C/métabolisme , Mâle , Protéines membranaires/génétique , Protéines membranaires/métabolisme , Souris , Acide oléanolique/pharmacologie , Sélectine P/génétique , Sélectine P/métabolisme , Myeloperoxidase/génétique , Myeloperoxidase/métabolisme , ARN messager/génétique , Récepteur cannabinoïde de type CB1/génétique , Récepteur cannabinoïde de type CB1/métabolisme , Récepteur cannabinoïde de type CB2/génétique , Récepteur cannabinoïde de type CB2/métabolisme , Facteur de nécrose tumorale alpha/génétique , Facteur de nécrose tumorale alpha/métabolismeRÉSUMÉ
Lepromatous macrophages possess a regulatory phenotype that contributes to the immunosuppression observed in leprosy. CD163, a scavenger receptor that recognizes hemoglobin-haptoglobin complexes, is expressed at higher levels in lepromatous cells, although its functional role in leprosy is not yet established. We herein demonstrate that human lepromatous lesions are microenvironments rich in IDOâºCD163âº. Cells isolated from these lesions were CD68âºIDOâºCD163⺠while higher levels of sCD163 in lepromatous sera positively correlated with IL-10 levels and IDO activity. Different Myco-bacterium leprae (ML) concentrations in healthy monocytes likewise revealed a positive correlation between increased concentrations of the mycobacteria and IDO, CD209, and CD163 expression. The regulatory phenotype in ML-stimulated monocytes was accompanied by increased TNF, IL-10, and TGF-ß levels whereas IL-10 blockade reduced ML-induced CD163 expression. The CD163 blockade reduced ML uptake in human monocytes. ML uptake was higher in HEK293 cells transfected with the cDNA for CD163 than in untransfected cells. Simultaneously, increased CD163 expression in lepromatous cells seemed to be dependent on ML uptake, and contributed to augmented iron storage in lepromatous macrophages. Altogether, these results suggest that ML-induced CD163 expression modulates the host cell phenotype to create a favorable environment for myco-bacterial entry and survival.
Sujet(s)
Antigènes CD/immunologie , Antigènes de différenciation des myélomonocytes/immunologie , Lèpre lépromateuse/immunologie , Lèpre lépromateuse/microbiologie , Macrophages/immunologie , Mycobacterium leprae/immunologie , Récepteurs de surface cellulaire/immunologie , Antigènes CD/génétique , Antigènes de différenciation des myélomonocytes/génétique , Biopsie , Cytométrie en flux , Humains , Indoleamine-pyrrole 2,3,-dioxygenase/immunologie , Interleukine-10/immunologie , Lèpre lépromateuse/anatomopathologie , Macrophages/microbiologie , ARN messager/composition chimique , ARN messager/génétique , Récepteurs de surface cellulaire/génétique , RT-PCRRÉSUMÉ
Cardiovascular development is the end result of a complex genetic program subject to regulation by signals transmitted between a cell and its extracellular environment. As cells encounter new extracellular matrices or establish new cell-cell interactions, new genes must be activated to accommodate the altered developmental situation within which the cell finds itself. This is likely reflected in a program of adhesion receptor and counter receptor expression on the surface of cells engaged in the morphogenesis. To understand the molecular basis of development, it is necessary to first determine if such a program exists and then to establish the role of various receptors and counter receptors in the particular morphogenetic process under investigation. To this end, we have initiated an investigation into expression of specific adhesion receptors during cardiovascular development in the mouse. Here, we demonstrate that platelet endothelial cell adhesion molecule (PECAM)-1 is an excellent marker for following vascular formation in the mammalian embryo. It is expressed during development in several alternatively spliced forms involving the cytoplasmic domain of the molecule. These forms differ in their ligand binding properties. Thus, a change in the cytoplasmic domain affects the folding of the molecule in such a way as to structurally alter the extracellular domain. Further, several receptors including the laminin receptor, the fibronectin receptor and a hyaluronic acid receptor, display specific expression patterns during heart development. These include differential expression in the endocardium and myocardium, down regulation during endocardial and myocardium, down regulation during endocardial cushion formation and cessation of expression in particular regions of the heart upon maturation. Interference with the function of one of these receptors (the fibronectin receptor) results in aberrant heart formation. These observations strongly support the concept that morphogenesis requires specific cell adhesion molecules that are expressed in precisely choreographed programs.